Harnessing <i>Lactobacillus reuteri</i> ‐Derived Extracellular Vesicles for Multifaceted Cancer Treatment (Small 10/2025)
Cancer Treatments Extracellular vesicles derived from the probiotic Lactobacillus reuteri (REVs) exhibit remarkable antitumor efficacy through oral administration, leveraging their stability in the gastrointestinal environment and inherent therapeutic effects. When combined with photothermal therapy, REVs encapsulating photosensitizers effectively target and eradicate lung tumors, highlighting their potential as a versatile platform for standalone or combinational cancer treatments. More in article number 2406094, Taejoon Kang, Juyeon Jung, and co-workers.
Authors
- Suhyeon Kim (ORCID: https://orcid.org/0000-0001-8375-2491)
- Eun‐Kyung Lim (ORCID: https://orcid.org/0000-0003-2793-3700)
- Jinsol Choi (ORCID: https://orcid.org/0000-0002-7308-9347)
- Eunkyeong Jung (ORCID: https://orcid.org/0000-0002-1164-1028)
- Juyeon Jung (ORCID: https://orcid.org/0000-0002-1969-321X)
- Hye Ran Kim (ORCID: https://orcid.org/0000-0002-0658-3345)
- Kwang-sun Kim (ORCID: https://orcid.org/0000-0003-3703-5461)
- Taejoon Kang (ORCID: https://orcid.org/0000-0002-5387-6458)
- Soyeon Yi
Institutions
- Korea University (KR)
- Sejong University (KR)
- Kyung Hee University (KR)
- Pusan National University (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Sungkyunkwan University (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Small
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1002/smll.202570073
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00